‘Telephone Outreach in Persons with Suicide attempts -a multi-center study’. This was an ICMR ad hoc extramural grant from 2018-2022.
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2018 - 2022
Project Lead
Priya Sreedaran, Uttara Chari (For Bengaluru site
Authors
Priya Sreedaran
Project Status
completed
Project Type
Randomized controlled trial